AbbVie Inc.
ABBVEquityAI Summary
Updated 8h ago
AbbVie Inc
AbbVie Inc. (ABBV) is in a mixed position. Some indicators are above average, others below, but nothing is at an extreme that demands attention. For reference: Flow Score 32/100, Trend & Momentum Score 68/100.
Market Positioning
What's Happening
AbbVie posts strong Q1 revenue and EPS beat
On 2026-04-29, AbbVie reported first-quarter 2026 adjusted diluted EPS of $2.65, up 7.7% year over year, on net revenues of $15.002 billion, up 12.4% reported and 10.3% operationally. The key takeaway is that the top line is still being carried by diversified growth across immunology and neuroscience, which helps offset investor concern that older franchise exposure will slow the overall business.
The Bigger Picture
Macro context will be updated shortly
Upcoming Catalysts
Updated 48d agoAbbVie’s next major update is expected around this date, with Wall Street consensus currently at $3.74 EPS and about $16.7 billion in revenue based on market estimates and company guidance.[2] Investors will focus on whether the first-quarter beat and raised outlook are holding through midyear.
AbbVie typically pairs its earnings release with a management call, giving investors the first detailed read on product momentum, margin discipline, and any guidance changes.[9] The commentary matters because AbbVie’s case depends heavily on execution across immunology and neuroscience.
Technical Analysis
Market Positioning
Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.
Key Levels
Looking at the full picture for AbbVie Inc. (ABBV): extension is neutral (48th percentile), momentum is below average (26th percentile), flow is below average (28th percentile), volatility is slightly above average (57th percentile).
Where is money flowing?
Trend
Is momentum building or fading?
What is the relative strength?
How extended is this move?
Where are the key levels?
What risk am I taking?
Conclusion
AbbVie Inc. (ABBV) is in a mixed position. Some indicators are above average, others below, but nothing is at an extreme level that defines the current setup strongly in either direction. There is not a strong signal here in either direction. This is an asset to watch rather than act on right now. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.
Your portfolio. Your context. Smarter decisions.
Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.
Personalized insights based on your actual holdings
Major market movements delivered to your inbox
Track the assets that matter most to you
No credit card required